Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan

J Pediatr. 2009 Aug;155(2):235-8.e1. doi: 10.1016/j.jpeds.2009.02.050. Epub 2009 May 15.

Abstract

Objective: To assess the etiology, prognosis, and appropriate treatment of hemophagocytic lymphohistiocytosis (HLH) in neonates.

Study design: We collected information on neonates in whom HLH was diagnosed between 1997 and 2007 from participating members of the Japanese Society of Pediatric Hematology.

Results: HLH was diagnosed in 20 patients within 4 weeks after birth. Of the diagnostic criteria for HLH-2004, the incidence of fever was quite low in preterm infants, and hypertriglyceridemia and neutropenia were uncommon. Familial HLH (n = 6) or severe combined immunodeficiency-associated HLH (n = 1) was diagnosed in 7 patients, and 2 of them have survived. Herpes simplex virus-associated HLH was diagnosed in 6 patients, and 2 of them have survived. The overall survival rate for the 20 patients was 40%.

Conclusions: HLH is rare in neonates and has a poor prognosis. Early diagnosis and immediate treatment are required when considering the possibility of herpes simplex virus-associated or familial HLH.

Publication types

  • Multicenter Study

MeSH terms

  • Acyclovir / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Antiviral Agents / therapeutic use
  • Consciousness Disorders / epidemiology
  • Cyclosporine / therapeutic use
  • Erythema / epidemiology
  • Etoposide / therapeutic use
  • Exanthema / epidemiology
  • Female
  • Fetal Distress / epidemiology
  • Fever / epidemiology
  • Hematopoietic Stem Cell Transplantation
  • Herpes Simplex / diagnosis
  • Herpes Simplex / drug therapy
  • Herpes Simplex / epidemiology
  • Humans
  • Immunologic Factors / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Infant, Newborn
  • Infant, Premature
  • Japan
  • L-Lactate Dehydrogenase / blood
  • Leukocytosis / epidemiology
  • Lymphohistiocytosis, Hemophagocytic / diagnosis*
  • Lymphohistiocytosis, Hemophagocytic / mortality*
  • Lymphohistiocytosis, Hemophagocytic / therapy
  • Male
  • Ocular Motility Disorders / epidemiology
  • Plasma Exchange
  • Prognosis
  • Respiratory Distress Syndrome, Newborn / epidemiology
  • Seizures / epidemiology
  • Severe Combined Immunodeficiency / diagnosis
  • Severe Combined Immunodeficiency / epidemiology
  • beta 2-Microglobulin / urine
  • gamma-Globulins / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents, Phytogenic
  • Antiviral Agents
  • Immunologic Factors
  • Immunosuppressive Agents
  • beta 2-Microglobulin
  • gamma-Globulins
  • Etoposide
  • Cyclosporine
  • L-Lactate Dehydrogenase
  • Acyclovir